Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept
Z. Khene, Romain Mathiéu, B. Peyronnet, Romain Kokorian, A. Gasmi, Fares Khene, Nathalie Rioux‐Leclercq, Solène‐Florence Kammerer‐Jacquet, Shahrokh F. Shariat, Brigitte Laguerre, Karim Bensalah
Topics & Concepts
MedicineRadiomicsRenal cell carcinomaNivolumabNephrologyInternal medicineOncologyKidney cancerImmunotherapyCancerRadiologyRadiomics and Machine Learning in Medical ImagingAdvanced X-ray and CT ImagingRenal cell carcinoma treatment